Study of MK-0472 in Participants With Advanced/Metastatic Solid Tumors (MK-0472-001)
Clinical trial NCT05853367 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05853367
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-06
- Primary completion
- 2028-06-24
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.